Abstract:8035 Background: Multiple myeloma (MM) is one of the most common primary tumors of the bone marrow that accounts for approximately 10% of all hematological cancer. Gambogenic acid (GNA) is one of the natural compound isolated from gamboge and has demonstrated advantages such as a more potent anticancer effect and less systemic toxicity according to early investigations. In this study, we hypothesized that GNA could synergistically potentiate BTZ-induced apoptosis of MM cells and that combining BTZ and GNA may provide a more effective approach to treat MM. Methods: CCK-8 assay, CI isobologram, flow cytometry, western blot, xenograft tumour models, TUNEL and immunochemistry were used in this study to detect to possible mechanisms of apoptosis led by GNA and BTZ in vitro and in vivo. Results: The percentage of MM.1S in G2/M phase after 48h of 4.0nM BTZ, 0.90μM GNA and combination treatment were 31.09±2.16%, 26.68±1.96% and 19.88±1.89% respectively. The percentage of MM.1S in G2/M phase of control group was 17.23±1.65%. The apoptosis rates of MM.1S cells for 48h were 6.57±0.15% in control group, 89.67±5.15% after treatment with 4.0nM BTZ, 97.80±0.81% after treatment with 0.90μM GNA, and 98.9±3.86% after treatment with 4.0nM BTZ plus 0.9μM GNA respectively. All the treatment groups showed a more significant apoptosis rate compared to that of the control group ( p<0.01). MM.1S tumors were implanted in BALB/Ca nu/nu male mice. The tumor weights of GNA and BTZ plus GNA groups decreased significantly when compared with those of control group (p<0.01 and p<0.001, respectively) and the tumor weight of combination group was significantly less than that of BTZ or GNA group (p<0.001). When mice were treated with BTZ combined with GNA, the tumor inhibition rate was 41.94%, whereas those of mice treated with BTZ or GNA alone were 9.68% and 19.35%, respectively. We also found that the combined treatment could induce more markedly increased apoptosis of MM.1S cells via the activation of PARP cleavage, P53, Caspase-3 cleavage and Bax and inhibition of Bcl-2 expression. Conclusions: Our data support that a synergistic antitumor activity exists between BTZ and GNA, and provide a rationale for successful utilization of dual BTZ and GNA in MM chemotherapy in the future.

Synergistic Anti-Proliferative Effects of Gambogic Acid with Docetaxel in Gastrointestinal Cancer Cell Lines

Enhancement of anticancer efficacy of chemotherapeutics by gambogic acid against gastric cancer cells.

The natural interaction between gambogic acid and oxaliplatin and its probably mechanism

Gambogenic Acid Synergistically Potentiates Bortezomib-Induced Apoptosis in Multiple Myeloma

Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma

Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells.

Combination of (-)-gossypol and docetaxel for lung cancer

Suppression of NF-κB Signaling and P-glycoprotein Function by Gambogic Acid Synergistically Potentiates Adriamycin -Induced Apoptosis in Lung Cancer.

Sequence-dependent antiproliferative effects of gefitinib combined with docetaxel in non-small cell lung cancer cells in vitro

Gambogic Acid Sensitizes Ovarian Cancer Cells to Doxorubicin Through ROS-Mediated Apoptosis

Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823.

Synergism of Gambogenic Acid with Bortezomib Induce Apoptosis of Multiple Myeloma.

The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma

Effect of Gambogic Acid on the Proliferation of Human Colon Carcinoma Cell SW480 and the Expression of VEGFR2

Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells.

Docetaxel and 5-FU enhanced the inhibitory effects of apatinib and ramucirumab on growth and migration of gastric cancer

Synergistic Inhibitory Effect of Wogonin and Low-Dose Paclitaxel on Gastric Cancer Cells and Tumor Xenografts

Gambogenic Acid Enhances Chemosensitivity of Multiple Myeloma to Bortezomib Through P53/ros/p38 MAPK Apoptotic Pathway

Gambogic Acid Improves Non-Small Cell Lung Cancer Progression by Inhibition of Mtor Signaling Pathway

Inhibition of EZH2 and EGFR produces a synergistic effect on cell apoptosis by increasing autophagy in gastric cancer cells.

Effects of Combination of Gefitinib and Docetaxel on Various Tumor Cell Lines in Vitro